25 XP   0   0   10

Cocrystal Pharma Inc
Buy, Hold or Sell?

Let's analyse Cocrystal Pharma Inc together

PenkeI guess you are interested in Cocrystal Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cocrystal Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cocrystal Pharma Inc

I send you an email if I find something interesting about Cocrystal Pharma Inc.

Quick analysis of Cocrystal Pharma Inc (30 sec.)










What can you expect buying and holding a share of Cocrystal Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.59
Expected worth in 1 year
$1.30
How sure are you?
45.0%

+ What do you gain per year?

Total Gains per Share
$-1.30
Return On Investment
-84.7%

For what price can you sell your share?

Current Price per Share
$1.53
Expected price per share
$1.4 - $1.65
How sure are you?
50%

1. Valuation of Cocrystal Pharma Inc (5 min.)




Live pricePrice per Share (EOD)

$1.53

Intrinsic Value Per Share

$-14.45 - $-8.16

Total Value Per Share

$-11.85 - $-5.57

2. Growth of Cocrystal Pharma Inc (5 min.)




Is Cocrystal Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$26.3m$51.6m-$20m-63.3%

How much money is Cocrystal Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.5m-$14.8m$10.3m229.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Cocrystal Pharma Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#549 / 1016

Most Revenue
#982 / 1016

Most Profit
#409 / 1016

Most Efficient
#427 / 1016

What can you expect buying and holding a share of Cocrystal Pharma Inc? (5 min.)

Welcome investor! Cocrystal Pharma Inc's management wants to use your money to grow the business. In return you get a share of Cocrystal Pharma Inc.

What can you expect buying and holding a share of Cocrystal Pharma Inc?

First you should know what it really means to hold a share of Cocrystal Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of Cocrystal Pharma Inc is $1.5299. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cocrystal Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cocrystal Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.59. Based on the TTM, the Book Value Change Per Share is $-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.93 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cocrystal Pharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.44-28.7%-0.42-27.2%-0.95-62.4%-0.63-41.1%-0.73-48.0%
Usd Book Value Change Per Share-0.42-27.7%-0.32-21.2%-0.93-61.0%0.021.3%0.085.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.42-27.7%-0.32-21.2%-0.93-61.0%0.021.3%0.085.2%
Usd Price Per Share1.72-1.99-0.80-1.38-1.30-
Price to Earnings Ratio-0.98--1.20--0.40--0.97--1.55-
Price-to-Total Gains Ratio-4.07-464.36--1.67-90.48-44.71-
Price to Book Ratio0.66-0.64-0.18-0.31-0.22-
Price-to-Total Gains Ratio-4.07-464.36--1.67-90.48-44.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.5299
Number of shares653
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.320.02
Usd Total Gains Per Share-0.320.02
Gains per Quarter (653 shares)-211.5412.68
Gains per Year (653 shares)-846.1850.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-846-85605141
20-1692-1702010192
30-2539-25480152143
40-3385-33940203194
50-4231-42400254245
60-5077-50860304296
70-5923-59320355347
80-6769-67780406398
90-7616-76240457449
100-8462-84700507500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%3.037.00.07.5%3.062.00.04.6%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%18.022.00.045.0%22.040.03.033.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.065.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%18.022.00.045.0%22.040.03.033.8%

Fundamentals of Cocrystal Pharma Inc

About Cocrystal Pharma Inc

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.

Fundamental data was last updated by Penke on 2024-04-11 04:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cocrystal Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cocrystal Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cocrystal Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4,186.5%+4,186.5%
5Y-4,186.5%10Y-3,819.7%-366.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y-4,186.5%-438.4%-3,748.1%
10Y-3,819.7%-605.5%-3,214.2%
1.1.2. Return on Assets

Shows how efficient Cocrystal Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • -14.3% Return on Assets means that Cocrystal Pharma Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cocrystal Pharma Inc:

  • The MRQ is -14.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.3%TTM-13.1%-1.2%
TTM-13.1%YOY-28.8%+15.7%
TTM-13.1%5Y-22.2%+9.1%
5Y-22.2%10Y-14.5%-7.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.3%-13.5%-0.8%
TTM-13.1%-12.9%-0.2%
YOY-28.8%-11.8%-17.0%
5Y-22.2%-14.1%-8.1%
10Y-14.5%-16.0%+1.5%
1.1.3. Return on Equity

Shows how efficient Cocrystal Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • -16.9% Return on Equity means Cocrystal Pharma Inc generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cocrystal Pharma Inc:

  • The MRQ is -16.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.9%TTM-14.4%-2.5%
TTM-14.4%YOY-30.4%+15.9%
TTM-14.4%5Y-23.9%+9.5%
5Y-23.9%10Y-16.6%-7.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.9%-16.9%0.0%
TTM-14.4%-16.1%+1.7%
YOY-30.4%-15.1%-15.3%
5Y-23.9%-19.9%-4.0%
10Y-16.6%-20.9%+4.3%

1.2. Operating Efficiency of Cocrystal Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cocrystal Pharma Inc is operating .

  • Measures how much profit Cocrystal Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cocrystal Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-3,641.5%+3,641.5%
5Y-3,641.5%10Y-1,184.6%-2,456.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y-3,641.5%-477.4%-3,164.1%
10Y-1,184.6%-625.6%-559.0%
1.2.2. Operating Ratio

Measures how efficient Cocrystal Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y39.206-39.206
5Y39.20610Y19.349+19.857
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y39.2065.679+33.527
10Y19.3497.894+11.455

1.3. Liquidity of Cocrystal Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cocrystal Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.92 means the company has $8.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 8.918. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.008. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.918TTM15.008-6.089
TTM15.008YOY28.668-13.660
TTM15.0085Y19.251-4.243
5Y19.25110Y10.668+8.583
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9183.914+5.004
TTM15.0084.220+10.788
YOY28.6685.388+23.280
5Y19.2516.045+13.206
10Y10.6686.406+4.262
1.3.2. Quick Ratio

Measures if Cocrystal Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.37 means the company can pay off $8.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 8.375. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.103. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.375TTM14.103-5.729
TTM14.103YOY27.605-13.501
TTM14.1035Y18.780-4.677
5Y18.78010Y10.450+8.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3753.572+4.803
TTM14.1033.998+10.105
YOY27.6055.390+22.215
5Y18.7805.969+12.811
10Y10.4506.287+4.163

1.4. Solvency of Cocrystal Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cocrystal Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cocrystal Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.16 means that Cocrystal Pharma Inc assets are financed with 15.6% credit (debt) and the remaining percentage (100% - 15.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.156. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.086. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.156TTM0.086+0.070
TTM0.086YOY0.038+0.048
TTM0.0865Y0.051+0.035
5Y0.05110Y0.186-0.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1560.336-0.180
TTM0.0860.334-0.248
YOY0.0380.269-0.231
5Y0.0510.366-0.315
10Y0.1860.390-0.204
1.4.2. Debt to Equity Ratio

Measures if Cocrystal Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 18.5% means that company has $0.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.185. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.096. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.185TTM0.096+0.089
TTM0.096YOY0.039+0.057
TTM0.0965Y0.055+0.041
5Y0.05510Y1.152-1.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1850.382-0.197
TTM0.0960.396-0.300
YOY0.0390.335-0.296
5Y0.0550.434-0.379
10Y1.1520.465+0.687

2. Market Valuation of Cocrystal Pharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cocrystal Pharma Inc generates.

  • Above 15 is considered overpriced but always compare Cocrystal Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -0.98 means the investor is paying $-0.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cocrystal Pharma Inc:

  • The EOD is -0.872. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.981. Based on the earnings, the company is expensive. -2
  • The TTM is -1.199. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.872MRQ-0.981+0.110
MRQ-0.981TTM-1.199+0.218
TTM-1.199YOY-0.402-0.798
TTM-1.1995Y-0.972-0.228
5Y-0.97210Y-1.546+0.574
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.872-2.259+1.387
MRQ-0.981-2.569+1.588
TTM-1.199-2.664+1.465
YOY-0.402-4.120+3.718
5Y-0.972-6.258+5.286
10Y-1.546-6.171+4.625
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cocrystal Pharma Inc:

  • The EOD is -1.332. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.500. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.492. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.332MRQ-1.500+0.167
MRQ-1.500TTM-1.492-0.007
TTM-1.492YOY-0.433-1.059
TTM-1.4925Y-1.527+0.035
5Y-1.52710Y-1.738+0.211
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.332-2.924+1.592
MRQ-1.500-3.246+1.746
TTM-1.492-3.488+1.996
YOY-0.433-5.620+5.187
5Y-1.527-8.315+6.788
10Y-1.738-8.826+7.088
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cocrystal Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.66 means the investor is paying $0.66 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cocrystal Pharma Inc:

  • The EOD is 0.590. Based on the equity, the company is cheap. +2
  • The MRQ is 0.664. Based on the equity, the company is cheap. +2
  • The TTM is 0.642. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.590MRQ0.664-0.074
MRQ0.664TTM0.642+0.022
TTM0.642YOY0.182+0.460
TTM0.6425Y0.311+0.331
5Y0.31110Y0.219+0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5901.851-1.261
MRQ0.6642.090-1.426
TTM0.6422.095-1.453
YOY0.1822.844-2.662
5Y0.3113.466-3.155
10Y0.2193.815-3.596
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cocrystal Pharma Inc.

3.1. Institutions holding Cocrystal Pharma Inc

Institutions are holding 6.72% of the shares of Cocrystal Pharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc2.7095027565600
2023-12-31Renaissance Technologies Corp1.22990.0003125128-1100-0.8714
2023-12-31BlackRock Inc0.72807406300
2023-12-31Geode Capital Management, LLC0.59406043200
2023-12-31Morgan Stanley - Brokerage Accounts0.58260592771482433.3476
2023-12-31Susquehanna International Group, LLP0.3395034544-37635-52.1412
2023-12-31State Street Corporation0.240302444300
2023-12-31Northern Trust Corp0.1201220700
2023-12-31Bank of America Corp0.088308979-49-0.5428
2023-12-31Tower Research Capital LLC0.05740.00015844249674.552
2023-12-31JPMorgan Chase & Co0.02160219645225.9174
2023-12-31UBS Group AG0.001601671670
2023-12-31Wells Fargo & Co0.000909233.3708
2023-12-31NVWM, LLC0.000808400
2023-12-31Royal Bank of Canada0.00010900
2023-12-31FMR Inc004-183-97.861
2023-09-30Parallel Advisors, LLC000-15228-100
2023-09-30Clean Yield Group Inc000-418-100
2023-12-31Archer Investment Corporation000-84-100
2023-09-30Advisor Group Holdings, Inc.000-2-100
Total 6.71450.0004683125-36757-5.4%

3.2. Funds holding Cocrystal Pharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.8809019135900
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.75410.00017672100
2024-02-29Fidelity Extended Market Index0.34270.000134865-169-0.4824
2024-02-29Fidelity Series Total Market Index0.08520866700
2024-02-29Fidelity Total Market Index0.08380852600
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.07450.00017576-183783-96.0409
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.07450757600
2023-12-31SSgA U.S. Extended Market Index Class I0.06360.0004646700
2024-03-31State St US Extended Mkt Indx NL Cl C0.06360.0005646700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06080.0002618200
2023-12-31Northern Trust Extended Eq Market Idx0.05260.0002535100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05260.0002535100
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04880.0002496590.1816
2024-02-29Fidelity Nasdaq Composite Index0.04150422300
2024-02-29Spartan Extended Market Index Pool E0.02160.000122001698.321
2024-02-29Spartan Total Market Index Pool E0.01880191500
2023-12-31SSgA U.S. Total Market Index Strategy0.01830.00011865-43-2.2537
2024-02-29State St US Ttl Mkt Indx SL Cl I0.008080900
2023-12-31BNYM Mellon SL Market Completion UC10.00540.0002551-9-1.6071
2023-12-31NT US Market Cap Idx Fd - L0.0038038800
Total 3.75510.0024382024-183826-48.1%

3.3. Insider Transactions

Insiders are holding 30.026% of the shares of Cocrystal Pharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-04-04Phillip Md Et Al FrostBUY10152291.97
2021-08-20Richard C. Pfenniger, Jr.BUY400001.03
2021-05-04Raymond F SchinaziSELL5750002.95

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cocrystal Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.423-0.324-23%-0.933+120%0.019-2279%0.080-632%
Book Value Per Share--2.5933.107-17%5.073-49%5.132-49%7.795-67%
Current Ratio--8.91815.008-41%28.668-69%19.251-54%10.668-16%
Debt To Asset Ratio--0.1560.086+82%0.038+316%0.051+205%0.186-16%
Debt To Equity Ratio--0.1850.096+92%0.039+372%0.055+235%1.152-84%
Dividend Per Share----0%-0%-0%-0%
Eps---0.439-0.417-5%-0.954+118%-0.628+43%-0.734+67%
Free Cash Flow Per Share---0.287-0.352+23%-0.529+84%-0.316+10%-0.269-6%
Free Cash Flow To Equity Per Share---0.304-0.256-16%-0.529+74%0.080-481%0.211-244%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.160--------
Intrinsic Value_10Y_min---14.446--------
Intrinsic Value_1Y_max---1.041--------
Intrinsic Value_1Y_min---1.578--------
Intrinsic Value_3Y_max---2.959--------
Intrinsic Value_3Y_min---4.656--------
Intrinsic Value_5Y_max---4.670--------
Intrinsic Value_5Y_min---7.618--------
Market Cap15564896.620-13%17521662.80020276978.200-14%8141583.450+115%14069517.849+25%15088834.989+16%
Net Profit Margin----0%-0%-41.8650%-38.1970%
Operating Margin----0%-0%-36.4150%-11.8460%
Operating Ratio----0%-0%39.206-100%19.349-100%
Pb Ratio0.590-13%0.6640.642+3%0.182+264%0.311+113%0.219+203%
Pe Ratio-0.872+11%-0.981-1.199+22%-0.402-59%-0.972-1%-1.546+58%
Price Per Share1.530-13%1.7221.993-14%0.800+115%1.383+25%1.305+32%
Price To Free Cash Flow Ratio-1.332+11%-1.500-1.4920%-0.433-71%-1.527+2%-1.738+16%
Price To Total Gains Ratio-3.614+11%-4.069464.362-101%-1.673-59%90.484-104%44.713-109%
Quick Ratio--8.37514.103-41%27.605-70%18.780-55%10.450-20%
Return On Assets---0.143-0.131-8%-0.288+102%-0.222+56%-0.145+2%
Return On Equity---0.169-0.144-15%-0.304+79%-0.239+41%-0.166-2%
Total Gains Per Share---0.423-0.324-23%-0.933+120%0.019-2279%0.080-632%
Usd Book Value--26384000.00031606250.000-17%51612250.000-49%52208400.000-49%80416300.000-67%
Usd Book Value Change Per Share---0.423-0.324-23%-0.933+120%0.019-2279%0.080-632%
Usd Book Value Per Share--2.5933.107-17%5.073-49%5.132-49%7.795-67%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.439-0.417-5%-0.954+118%-0.628+43%-0.734+67%
Usd Free Cash Flow---2920779.000-3580330.663+23%-5377250.000+84%-3217866.133+10%-2773758.066-5%
Usd Free Cash Flow Per Share---0.287-0.352+23%-0.529+84%-0.316+10%-0.269-6%
Usd Free Cash Flow To Equity Per Share---0.304-0.256-16%-0.529+74%0.080-481%0.211-244%
Usd Market Cap15564896.620-13%17521662.80020276978.200-14%8141583.450+115%14069517.849+25%15088834.989+16%
Usd Price Per Share1.530-13%1.7221.993-14%0.800+115%1.383+25%1.305+32%
Usd Profit---4464000.000-4515500.000+1%-14885000.000+233%-9843050.000+120%-9290450.000+108%
Usd Revenue----0%-0%454671.350-100%120207.775-100%
Usd Total Gains Per Share---0.423-0.324-23%-0.933+120%0.019-2279%0.080-632%
 EOD+3 -5MRQTTM+6 -23YOY+19 -105Y+13 -1810Y+10 -21

4.2. Fundamental Score

Let's check the fundamental score of Cocrystal Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.872
Price to Book Ratio (EOD)Between0-10.590
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.375
Current Ratio (MRQ)Greater than18.918
Debt to Asset Ratio (MRQ)Less than10.156
Debt to Equity Ratio (MRQ)Less than10.185
Return on Equity (MRQ)Greater than0.15-0.169
Return on Assets (MRQ)Greater than0.05-0.143
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Cocrystal Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.891
Ma 20Greater thanMa 501.496
Ma 50Greater thanMa 1001.495
Ma 100Greater thanMa 2001.606
OpenGreater thanClose1.545
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Reconciled Depreciation  1003103-21017108-1,808-1,700
Depreciation and Amortization  1003103-21017108-1,808-1,700



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets31,259
Total Liabilities4,875
Total Stockholder Equity26,384
 As reported
Total Liabilities 4,875
Total Stockholder Equity+ 26,384
Total Assets = 31,259

Assets

Total Assets31,259
Total Current Assets29,091
Long-term Assets2,168
Total Current Assets
Cash And Cash Equivalents 26,428
Net Receivables 890
Other Current Assets 1,773
Total Current Assets  (as reported)29,091
Total Current Assets  (calculated)29,091
+/-0
Long-term Assets
Property Plant Equipment 2,122
Long-term Assets Other 46
Long-term Assets  (as reported)2,168
Long-term Assets  (calculated)2,168
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,262
Long-term Liabilities1,613
Total Stockholder Equity26,384
Total Current Liabilities
Short-term Debt 240
Accounts payable 1,222
Other Current Liabilities 1,800
Total Current Liabilities  (as reported)3,262
Total Current Liabilities  (calculated)3,262
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,613
Long-term Liabilities  (as reported)1,613
Long-term Liabilities  (calculated)1,613
+/-0
Total Stockholder Equity
Common Stock10
Retained Earnings -315,914
Other Stockholders Equity 342,288
Total Stockholder Equity (as reported)26,384
Total Stockholder Equity (calculated)26,384
+/-0
Other
Capital Stock10
Cash and Short Term Investments 26,428
Common Stock Shares Outstanding 10,174
Liabilities and Stockholders Equity 31,259
Net Debt -24,575
Net Invested Capital 26,384
Net Working Capital 25,829
Property Plant and Equipment Gross 3,925
Short Long Term Debt Total 1,853



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-30
> Total Assets 
-5
171
162
148
142
137
125
121
117
113
113
94
91
89
2,337
11,120
10,706
7,547
7,547
9,071
8,260
7,240
7,240
7,701
7,597
6,456
10,481
12,967
11,635
259,283
268,603
269,129
266,160
224,230
225,168
220,148
220,901
124,883
122,518
124,340
122,253
121,426
120,721
126,325
124,171
68,562
68,562
74,907
73,437
28,531
42,841
40,478
53,216
54,242
53,851
87,417
82,598
79,392
75,372
52,383
45,647
40,840
37,841
36,279
32,614
31,259
31,25932,61436,27937,84140,84045,64752,38375,37279,39282,59887,41753,85154,24253,21640,47842,84128,53173,43774,90768,56268,562124,171126,325120,721121,426122,253124,340122,518124,883220,901220,148225,168224,230266,160269,129268,603259,28311,63512,96710,4816,4567,5977,7017,2407,2408,2609,0717,5477,54710,70611,1202,337899194113113117121125137142148162171-5
   > Total Current Assets 
-5
110
100
85
80
75
63
54
50
46
46
28
25
23
2,122
6,444
6,056
2,904
2,904
4,369
3,644
2,670
2,670
3,235
2,826
6,456
10,037
10,097
5,803
6,376
15,754
16,329
13,225
9,919
10,916
5,936
6,755
5,472
3,100
4,941
2,879
2,176
1,481
7,099
4,991
2,943
2,943
8,533
7,013
8,281
22,582
20,102
32,899
34,015
33,691
67,337
62,441
59,323
55,399
51,596
44,896
40,178
37,236
35,761
32,205
29,091
29,09132,20535,76137,23640,17844,89651,59655,39959,32362,44167,33733,69134,01532,89920,10222,5828,2817,0138,5332,9432,9434,9917,0991,4812,1762,8794,9413,1005,4726,7555,93610,9169,91913,22516,32915,7546,3765,80310,09710,0376,4562,8263,2352,6702,6703,6444,3692,9042,9046,0566,4442,1222325284646505463758085100110-5
       Cash And Cash Equivalents 
-1
110
95
85
79
75
62
49
46
43
43
27
25
23
2,122
1,840
782
416
416
174
83
62
62
354
530
589
2,599
4,074
3,006
3,970
14,257
15,781
12,413
9,276
10,242
5,022
5,906
3,640
1,555
3,451
1,345
748
1,249
6,841
4,684
2,723
2,723
7,474
5,994
7,418
21,686
19,315
31,781
33,010
33,278
67,062
61,644
58,705
54,789
51,033
42,056
37,144
33,981
32,419
29,738
26,428
26,42829,73832,41933,98137,14442,05651,03354,78958,70561,64467,06233,27833,01031,78119,31521,6867,4185,9947,4742,7232,7234,6846,8411,2497481,3453,4511,5553,6405,9065,02210,2429,27612,41315,78114,2573,9703,0064,0742,5995895303546262831744164167821,8402,122232527434346496275798595110-1
       Short-term Investments 
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,285
5,719
2,500
1,975
993
0
0
0
0
0
0
0
0
0
0
29
29
29
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000002929292900000000009931,9752,5005,7197,2850000000000000000000000000-4
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,671
1,826
523
523
1,261
920
835
835
1,153
362
139
0
148
181
287
312
184
180
202
188
226
224
1,315
1,294
1,294
1,294
1,295
1,295
0
0
0
1,078
914
768
644
644
592
581
556
556
0
0
0
0
0
0
716
956
1,207
550
890
8905501,2079567160000005565565815926446447689141,0780001,2951,2951,2941,2941,2941,31522422618820218018431228718114801393621,1538358359201,2615235231,8261,671000000000000000
       Other Current Assets 
0
0
5
0
0
1
1
5
4
0
3
1
0
0
0
94
60
0
145
562
490
0
122
203
208
5,867
153
156
116
144
192
364
632
441
486
688
625
517
251
196
240
104
203
229
278
220
191
95
201
169
202
145
487
399
363
225
747
568
560
488
2,765
2,243
2,224
2,060
1,842
1,773
1,7731,8422,0602,2242,2432,765488560568747225363399487145202169201951912202782292031042401962515176256884864416323641921441161561535,867208203122049056214506094000130451100500
   > Long-term Assets 
0
61
62
62
62
62
62
67
67
0
67
67
67
67
214
4,677
4,650
0
4,642
4,703
4,616
0
4,569
4,466
4,771
3,692
444
2,870
5,832
252,907
252,849
252,800
252,935
214,311
214,252
214,212
214,146
119,411
119,418
119,399
119,374
119,250
119,240
119,226
119,180
65,619
65,619
66,374
66,424
20,250
20,259
20,376
20,317
20,227
20,160
20,080
20,157
20,069
19,973
787
751
662
605
518
409
2,168
2,16840951860566275178719,97320,06920,15720,08020,16020,22720,31720,37620,25920,25066,42466,37465,61965,619119,180119,226119,240119,250119,374119,399119,418119,411214,146214,212214,252214,311252,935252,800252,849252,9075,8322,8704443,6924,7714,4664,56904,6164,7034,64204,6504,67721467676767067676262626262610
       Property Plant Equipment 
0
0
1
1
1
1
1
6
6
6
6
5
5
5
5
3,139
3,187
3,342
3,342
3,410
3,344
3,334
3,334
3,263
3,133
2,531
412
361
314
284
245
215
369
430
392
357
320
280
287
268
243
119
109
95
31
384
384
1,129
1,179
1,108
1,128
1,249
1,179
1,089
1,022
942
1,019
931
835
741
705
616
559
472
363
2,122
2,1223634725596167057418359311,0199421,0221,0891,1791,2491,1281,1081,1791,12938438431951091192432682872803203573924303692152452843143614122,5313,1333,2633,3343,3343,3443,4103,3423,3423,1873,139555566661111100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,299
1,354
1,027
1,027
1,027
1,027
1,027
1,027
1,027
1,027
1,027
0
0
0
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
0
0
0
0
0
0
0
000000019,09219,09219,09219,09219,09219,09219,09219,09219,09219,09265,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,1950001,0271,0271,0271,0271,0271,0271,0271,0271,0271,3541,299000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,496
2,431
2,412
2,393
2,374
2,354
2,333
2,303
2,276
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000002,2762,3032,3332,3542,3742,3932,4122,4315,4960000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
247
247
219
205
191
191
163
148
134
0
0
0
184,966
184,966
184,966
184,966
146,301
146,301
146,301
146,301
53,905
53,905
53,905
53,905
53,905
53,905
53,905
53,905
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000053,90553,90553,90553,90553,90553,90553,90553,905146,301146,301146,301146,301184,966184,966184,966184,96600013414816319119120521924724700000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,692
32
2,509
5,518
252,623
252,604
252,585
252,566
213,881
213,860
213,855
213,826
119,131
119,131
119,131
119,131
119,131
53,936
53,936
53,954
40
40
50
50
50
39
35
590
544
46
46
46
46
46
0
46
0
0
46
0
0
00460046046464646465445903539505050404053,95453,93653,936119,131119,131119,131119,131119,131213,826213,855213,860213,881252,566252,585252,604252,6235,5182,50932-3,6920000000000000000000000000
> Total Liabilities 
0
24
36
36
38
42
46
50
52
58
58
63
76
82
2,334
10,754
10,883
10,316
10,316
13,003
8,335
10,820
10,820
13,010
18,051
12,482
12,555
6,911
7,657
252,632
79,905
72,606
69,407
56,636
55,825
53,315
53,079
22,564
22,535
22,304
22,255
16,026
16,585
13,679
13,270
1,674
1,674
2,489
2,692
2,823
2,410
3,423
3,039
1,737
1,793
2,669
1,586
1,843
1,792
2,990
1,738
1,273
3,172
1,597
1,924
4,875
4,8751,9241,5973,1721,2731,7382,9901,7921,8431,5862,6691,7931,7373,0393,4232,4102,8232,6922,4891,6741,67413,27013,67916,58516,02622,25522,30422,53522,56453,07953,31555,82556,63669,40772,60679,905252,6327,6576,91112,55512,48218,05113,01010,82010,8208,33513,00310,31610,31610,88310,7542,334827663585852504642383636240
   > Total Current Liabilities 
0
24
36
36
38
42
46
50
52
58
58
63
76
82
2,334
7,543
7,796
7,278
7,278
10,049
5,421
7,926
7,926
10,108
15,287
12,482
12,555
6,911
7,657
9,157
14,648
7,349
4,151
6,700
5,891
3,383
3,150
2,039
2,026
1,800
1,756
1,406
1,358
1,053
1,137
1,557
1,557
1,854
2,105
2,286
1,925
2,943
2,614
1,358
1,457
2,379
1,228
1,545
1,558
2,813
1,619
1,216
3,145
1,587
1,924
3,262
3,2621,9241,5873,1451,2161,6192,8131,5581,5451,2282,3791,4571,3582,6142,9431,9252,2862,1051,8541,5571,5571,1371,0531,3581,4061,7561,8002,0262,0393,1503,3835,8916,7004,1517,34914,6489,1577,6576,91112,55512,48215,28710,1087,9267,9265,42110,0497,2787,2787,7967,5432,334827663585852504642383636240
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,741
4,134
261
3,410
2,576
1,422
1,654
2,754
3,493
2,421
156
12,089
6,450
7,242
8,464
13,456
6,130
3,096
4,115
2,807
1,869
1,907
1,476
905
707
855
569
548
288
159
477
214
370
325
280
232
226
228
217
203
190
233
236
243
242
241
240
208
166
118
240
2401181662082402412422432362331902032172282262322803253702144771592885485698557079051,4761,9071,8692,8074,1153,0966,13013,4568,4647,2426,45012,0891562,4213,4932,7541,6541,4222,5763,4102614,1345,741000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,464
0
0
0
4,115
0
1,869
1,907
1,476
905
707
855
1,007
2,039
0
0
0
161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001610002,0391,0078557079051,4761,9071,86904,1150008,46400000000000000000000000000000
       Accounts payable 
0
24
36
36
38
0
0
0
0
0
0
0
0
0
82
1,435
2,725
0
1,617
1,608
1,019
0
736
1,462
209
255
289
180
125
299
737
838
724
2,585
3,084
1,514
1,243
563
1,121
1,093
901
837
810
765
978
1,077
616
1,071
1,092
1,511
922
832
1,485
657
748
939
491
578
858
616
897
614
2,654
1,041
568
1,222
1,2225681,0412,6546148976168585784919397486571,4858329221,5111,0921,0716161,0779787658108379011,0931,1215631,2431,5143,0842,5857248387372991251802892552091,46273601,0191,6081,61702,7251,43582000000000383636240
       Other Current Liabilities 
0
0
0
0
0
42
46
50
52
0
58
63
76
82
2,252
366
936
0
2,251
5,865
595
0
4,334
902
8,062
11,969
12,266
6,731
7,532
8,858
13,911
6,511
3,427
4,115
2,807
1,869
1,907
1,476
905
707
855
569
548
288
159
3
263
123
90
7
34
77
36
61
60
51
34
12
457
1,955
481
362
283
380
1,806
1,800
1,8001,8063802833624811,955457123451606136773479012326331592885485698557079051,4761,9071,8692,8074,1153,4276,51113,9118,8587,5326,73112,26611,9698,0629024,33405955,8652,25109363662,2528276635805250464200000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,211
3,087
0
3,038
2,954
2,913
0
2,895
2,901
2,764
2,711
0
0
0
243,475
65,257
65,257
65,256
49,936
49,934
49,932
49,929
20,525
20,509
20,504
20,499
14,620
15,227
12,626
12,133
117
117
635
587
537
485
480
425
379
336
290
358
298
234
177
119
57
27
10
0
1,613
1,613010275711917723429835829033637942548048553758763511711712,13312,62615,22714,62020,49920,50420,50920,52549,92949,93249,93449,93665,25665,25765,257243,4750002,7112,7642,9012,89502,9132,9543,03803,0873,211000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,211
3,087
0
0
0
0
0
0
0
0
0
0
0
0
65,257
0
0
0
49,936
0
0
0
0
0
0
0
1,007
2,039
0
0
117
61
21
18
14
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001014182161117002,0391,007000000049,93600065,2570000000000003,0873,211000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62
62
62
61
61
59
57
54
63
47
42
37
31
13,188
12,626
12,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000012,13312,62613,1883137424763545759616162626200000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
184,966
65,257
65,257
65,256
146,301
49,934
49,932
49,929
20,525
20,509
20,504
20,499
13,613
13,188
12,626
12,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000012,13312,62613,18813,61320,49920,50420,50920,52549,92949,93249,934146,30165,25665,25765,257184,96600000000000000000000000000000
> Total Stockholder Equity
192
148
127
113
105
97
80
73
67
0
57
34
19
10
6
366
-178
0
-2,769
-3,932
-75
0
-3,580
-5,309
-10,455
-6,026
-2,074
6,056
3,978
6,651
188,698
196,523
196,753
167,594
169,343
166,833
167,822
102,319
99,983
102,036
99,998
105,400
104,136
112,646
110,901
66,888
66,888
72,418
70,745
25,708
40,431
37,055
50,177
52,505
52,058
84,748
81,012
77,549
73,580
49,393
43,909
39,567
34,669
34,682
30,690
26,384
26,38430,69034,68234,66939,56743,90949,39373,58077,54981,01284,74852,05852,50550,17737,05540,43125,70870,74572,41866,88866,888110,901112,646104,136105,40099,998102,03699,983102,319167,822166,833169,343167,594196,753196,523188,6986,6513,9786,056-2,074-6,026-10,455-5,309-3,5800-75-3,932-2,7690-178366610193457067738097105113127148192
   Common Stock
192
4
4
4
4
4
4
4
4
0
4
4
4
4
38
67
68
0
55
62
63
0
63
69
70
114
122
122
123
123
687
694
694
694
704
704
714
714
714
727
728
24
24
30
30
30
30
32
32
36
53
53
69
71
72
98
98
98
98
98
8
8
8
10
10
10
10101088898989898987271695353363232303030302424728727714714714704704694694694687123123122122114706963063625506867384444044444444192
   Retained Earnings -315,914-311,450-307,285-303,119-297,930-293,429-287,729-263,301-259,093-255,408-251,467-247,646-244,908-243,415-240,745-237,250-235,260-187,415-185,635-187,091-187,091-142,805-140,940-139,596-138,043-143,240-140,981-139,978-137,430-71,676-69,795-66,568-62,556-32,107-31,599-28,976-12,434-10,527-7,978-12,707-33,750-21,658-16,350-14,128-14,128-10,623-17,412-6,163-6,163-4,373-2,033-209-204-196-180-156-156-145-139-132-114-106-97-83-620
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
-1
-1
-1
-1
-1
-1
0
-4,224
-4,307
-4,558
-4,558
-4,765
-4,871
-4,929
-4,929
0
-5,280
0
-1,451
1,827
2,235
236
-744
0
0
-1,153
-1,153
0
0
-1,354
-1,354
0
0
-1,358
-1,358
0
0
-983
-983
-1,028
-1,053
-1,081
-1,111
-1,056
-1,102
0
-1,159
0
0
0
0
0
0
0
0
0
0
0
00000000000-1,1590-1,102-1,056-1,111-1,081-1,053-1,028-983-98300-1,358-1,35800-1,354-1,35400-1,153-1,15300-7442362,2351,827-1,4510-5,2800-4,929-4,929-4,871-4,765-4,558-4,558-4,307-4,2240-1-1-1-1-1-100000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,332
4,128
0
0
0
0
0
0
0
0
27,610
11,961
12,084
12,146
18,725
217,731
227,428
228,166
229,456
235,207
235,924
238,784
239,035
239,247
242,290
242,510
243,419
243,708
253,556
253,676
253,949
257,908
258,021
258,128
260,932
277,628
277,747
293,523
297,342
299,632
336,117
0
0
0
0
0
0
0
341,957
0
0
00341,9570000000336,117299,632297,342293,523277,747277,628260,932258,128258,021257,908253,949253,676253,556243,708243,419242,510242,290239,247239,035238,784235,924235,207229,456228,166227,428217,73118,72512,14612,08411,96127,610000000004,1282,332000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--1,388
Gross Profit1,3881,388
 
Operating Income (+$)
Gross Profit1,388
Operating Expense-22,547
Operating Income-21,159-21,159
 
Operating Expense (+$)
Research Development15,169
Selling General Administrative5,806
Selling And Marketing Expenses0
Operating Expense22,54720,975
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-460
Net Interest Income460
 
Pretax Income (+$)
Operating Income-21,159
Net Interest Income460
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,984-24,334
EBIT - interestExpense = -21,159
-17,984
-17,984
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-21,159-17,984
Earnings Before Interest and Taxes (EBITDA)-22,547
 
After tax Income (+$)
Income Before Tax-17,984
Tax Provision-0
Net Income From Continuing Ops-18,021-17,984
Net Income-17,984
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses21,159
Total Other Income/Expenses Net3,175-460
 

Technical Analysis of Cocrystal Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cocrystal Pharma Inc. The general trend of Cocrystal Pharma Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cocrystal Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cocrystal Pharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.62 < 1.65 < 1.65.

The bearish price targets are: 1.4 > 1.4 > 1.4.

Tweet this
Cocrystal Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cocrystal Pharma Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cocrystal Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cocrystal Pharma Inc. The current macd is -0.00423016.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cocrystal Pharma Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cocrystal Pharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cocrystal Pharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cocrystal Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartCocrystal Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cocrystal Pharma Inc. The current adx is 19.25.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cocrystal Pharma Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Cocrystal Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cocrystal Pharma Inc. The current sar is 1.61722817.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cocrystal Pharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cocrystal Pharma Inc. The current rsi is 52.89. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Cocrystal Pharma Inc Daily Relative Strength Index (RSI) ChartCocrystal Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cocrystal Pharma Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cocrystal Pharma Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cocrystal Pharma Inc Daily Stochastic Oscillator ChartCocrystal Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cocrystal Pharma Inc. The current cci is 65.33.

Cocrystal Pharma Inc Daily Commodity Channel Index (CCI) ChartCocrystal Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cocrystal Pharma Inc. The current cmo is 10.01.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cocrystal Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartCocrystal Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cocrystal Pharma Inc. The current willr is -43.78125.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cocrystal Pharma Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cocrystal Pharma Inc Daily Williams %R ChartCocrystal Pharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cocrystal Pharma Inc.

Cocrystal Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cocrystal Pharma Inc. The current atr is 0.11318008.

Cocrystal Pharma Inc Daily Average True Range (ATR) ChartCocrystal Pharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cocrystal Pharma Inc. The current obv is 846,628.

Cocrystal Pharma Inc Daily On-Balance Volume (OBV) ChartCocrystal Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cocrystal Pharma Inc. The current mfi is 71.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cocrystal Pharma Inc Daily Money Flow Index (MFI) ChartCocrystal Pharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cocrystal Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Cocrystal Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cocrystal Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.891
Ma 20Greater thanMa 501.496
Ma 50Greater thanMa 1001.495
Ma 100Greater thanMa 2001.606
OpenGreater thanClose1.545
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cocrystal Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on Cocrystal Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cocrystal Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cocrystal Pharma Inc

I send you an email if I find something interesting about Cocrystal Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cocrystal Pharma Inc.

Receive notifications about Cocrystal Pharma Inc in your mailbox!